MCLEVISH TIMOTHY R
MCLEVISH TIMOTHY R's purchase track record
How the stock did after each of MCLEVISH TIMOTHY R's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 5/18/2026 | FRPT | $146K | +50.0% | pending | — |
| 9/10/2025 | FRPT | $196K | +19.5% | +50.4% | +3.7% |
| 3/14/2025 | FRPT | $155K | -15.4% | -37.6% | +16.8% |
| 2/24/2025 | FRPT | $210K | -22.8% | -47.7% | +7.6% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Freshpet Q2 Earnings Call Held; Wells Fargo Lowers Price Target. Freshpet held its Q2 2026 earnings call, a key event for investors tracking the pet food maker. Following the release, Wells Fargo maintained an Overweight rating but lowered its price target to $77. This adjustment places the bank's view below the current average analyst target of $84.25, reflecting a more cautious outlook on the stock's valuation.
Transaction History
| LW | ▲ Buy | Grant | 5,458 | $0 | 10/8/2026 | View on chart |
| FRPT | ▲ Buy | Open Market | 3,000 | $146K | 5/18/2026 | View on chart |
| FRPT | ▲ Buy | Grant | 1,589 | $0 | 3/10/2026 | View on chart |
| LW | ▲ Buy | Grant | 4,345 | $0 | 10/2/2025 | View on chart |
| FRPT | ▲ Buy | Open Market | 3,500 | $196K | 9/10/2025 | View on chart |
| LW | ▲ Buy | Grant | 1,109 | $0 | 7/25/2025 | View on chart |
| FRPT | ▲ Buy | Open Market | 1,250 | $110K | 3/14/2025 | View on chart |
| FRPT | ▲ Buy | Open Market | 500 | $45K | 3/14/2025 | View on chart |
| FRPT | ▲ Buy | Grant | 1,432 | $0 | 3/11/2025 | View on chart |
| FRPT | ▲ Buy | Open Market | 500 | $51K | 2/25/2025 | View on chart |
| FRPT | ▲ Buy | Open Market | 250 | $26K | 2/25/2025 | View on chart |
| FRPT | ▲ Buy | Open Market | 250 | $26K | 2/25/2025 | View on chart |
| FRPT | ▲ Buy | Open Market | 750 | $80K | 2/25/2025 | View on chart |
| FRPT | ▲ Buy | Open Market | 250 | $26K | 2/24/2025 | View on chart |
| FRPT | ▲ Buy | Grant | 1,095 | $0 | 3/15/2024 | View on chart |
| FRPT | ▲ Buy | Grant | 1,513 | $0 | 8/21/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 7, 2026
Lamb Weston Shares Rise After Earnings Call and Cost‑Savings Highlights
Lamb Weston reported its first‑quarter 2027 results, noting stronger earnings and new cost‑saving initiatives that are expected to lift profitability. The company’s shares moved higher on Wednesday, joining a group of consumer stocks that gained in the session. Analysts highlighted the cost‑efficiency measures as a key driver for the price lift. The move comes amid a broader market rally that saw the S&P 500 hit a record high.
Lamb Weston Shares Rise After Earnings Call and Cost‑Savings Highlights. Lamb Weston reported its first‑quarter 2027 results, noting stronger earnings and new cost‑saving initiatives that are expected to lift profitability. The company’s shares moved higher on Wednesday, joining a group of consumer stocks that gained in the session. Analysts highlighted the cost‑efficiency measures as a key driver for the price lift. The move comes amid a broader market rally that saw the S&P 500 hit a record high.